| ²é¿´: 679 | »Ø¸´: 1 | |||
scilence28гæ (СÓÐÃûÆø)
|
[ÇóÖú]
¼òµ¥µÄ·Ò룬¼±Ç󡣡£¡£ ÒÑÓÐ1È˲ÎÓë
|
| µ±½ñҩѧÁìÓò£¬°üºÏÎïºÍÖ¬ÖÊÌå×÷ΪҩÎïµÄÔØÌå¹ã·ºÓÃÓÚÒ©ÎïµÄÖÆ±¸£¬¸÷×Ô·¢»Ó×ÅÆä×ÔÉíµÄ°ÐÏòÓÅÊÆ¡£Îª¸üºÃµÄ½â¾ö°Ðϸ°û¸øÒ©ÎÊÌ⣬ʹÓðüºÏÎïÖ¬ÖÊÌåÀ´×÷ΪҩÎïÔËÊäÔØÌå¡£±¾ÎÄ×ÛÊöÁËͨ¹ý½áºÏ°üºÏÎïºÍÖ¬ÖÊÌåµÄ²»Í¬ÓÅÊÆÀ´¿ØÖÆÒ©ÎïµÄÎȶ¨ÐÔ¼°ÔØÒ©Á¿µÄÎÊÌ⣬Ìá¸ßÒ©ÎïµÄÎüÊÕºÍÁÙ´²ÁÆÐ§£¬Îª½ñºó°ÐÏò¸øÒ©ÏµÍ³µÄ½øÒ»²½Ñо¿ÌṩÀíÂÛÒÀ¾Ý£¬²¢½øÒ»²½Õ¹Íû½ñºóµÄ·¢Õ¹·½Ïò¡£ |
» ²ÂÄãϲ»¶
271²ÄÁϹ¤³ÌÇóµ÷¼Á
ÒѾÓÐ5È˻ظ´
281Çóµ÷¼Á£¨0805£©
ÒѾÓÐ16È˻ظ´
304Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
²ÄÁϹ¤³Ìר˶µ÷¼Á
ÒѾÓÐ6È˻ظ´
Ò»Ö¾Ô¸Ìì´ó²ÄÁÏÓ뻯¹¤£¨085600£©×Ü·Ö338
ÒѾÓÐ4È˻ظ´
085700×ÊÔ´Óë»·¾³308Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
Çó²ÄÁϵ÷¼Á
ÒѾÓÐ8È˻ظ´
294Çóµ÷¼Á²ÄÁÏÓ뻯¹¤×¨Ë¶
ÒѾÓÐ5È˻ظ´
Ò»Ö¾Ô¸»ªÖпƼ¼´óѧ£¬080502£¬354·ÖÇóµ÷¼Á
ÒѾÓÐ4È˻ظ´
Ò»Ö¾Ô¸¼ªÁÖ´óѧ²ÄÁÏѧ˶321Çóµ÷¼Á
ÒѾÓÐ6È˻ظ´
» ±¾Ö÷ÌâÏà¹Ø¼ÛÖµÌùÍÆ¼ö£¬¶ÔÄúͬÑùÓаïÖú:
Çó·ÒëÕâһС¶Î£¬²»Éõ¸Ð¼¤£¡£¡£¡£¡
ÒѾÓÐ6È˻ظ´
¾¥¸ù±ÈÔõô·Òë
ÒѾÓÐ6È˻ظ´
ÖÐÎÄÑо¿¼Æ»®ºÍÓ¢ÎÄÑо¿¼Æ»®
ÒѾÓÐ7È˻ظ´
ÇóÖú¸ß·Ö×ӵĴóÉñ½âÊÍÒ»¸ö¼òµ¥ÎÊÌ⣬ϣÍûÄÜÓÃרҵµÄÓïÑÔ½â´ð£¡
ÒѾÓÐ14È˻ظ´
¼ò¶Ì¾ä×Ó·Òë¡£¡£Çó´óÅ£½â´ð¡£¡£ÔÚÏßµÈŶ
ÒѾÓÐ9È˻ظ´
ÇóÖú·ÒëÒ»¶ÎÓ¢ÎÄ
ÒѾÓÐ1È˻ظ´
ÇóÖúÒ»¶ÎÎÄÏ×ÕªÒªµÄ·Òë
ÒѾÓÐ4È˻ظ´
Çó´óÉñ¸ø¸ö·Òë
ÒѾÓÐ3È˻ظ´
Ò»¶ÎÓ¢ÎÄ·Òë³ÉÖÐÎÄ Ôõô¶Ï¾ä
ÒѾÓÐ2È˻ظ´
Çë¸ßÈ˰ïæ·ÒëÒ»ÏÂÕâ¸ö¾ä×Ó
ÒѾÓÐ2È˻ظ´
14Ä꿼Ñе³ ÇóÓ¢Óï¶þ ¸´Ï°×ÊÁϵÄÑ¡Ôñ Çó¿¼¹ýµÄ´óÉñÍÆ¼ö~~
ÒѾÓÐ12È˻ظ´
¹ØÓÚÑÐÐ޼ƻ®ºÍresearch proposal
ÒѾÓÐ11È˻ظ´
ÎÊÒ»¶ÎÓ¢ÎÄ·Ò룬³¬¼òµ¥µÄ£¬¾ÍÊDZ¾È˸Õ×öÓлú
ÒѾÓÐ8È˻ظ´
Çó´óÉñ°ÑÓ¢ÎİæµÄ»¯Ñ§Í¨ÓÃÃû·Òë³ÉÖÐÎÄ
ÒѾÓÐ5È˻ظ´
¹ØÓÚÒâ´óÀûǩ֤µÄ³öÉúÖ¤Ã÷
ÒѾÓÐ4È˻ظ´
»¯Ñ§ºÏ³É²½Ö裬·Òë¹ýÁ˲»ÊÇÌ«Ã÷°×£¡¼±ÇóÖú
ÒѾÓÐ5È˻ظ´
ÇëѧÊýѧµÄ¸ø×Ô¼ºÍƼöÒ»±¾¼òµ¥Ò×¶®ÓÐÀý×ÓµÄͳ¼ÆÑ§Êé
ÒѾÓÐ10È˻ظ´
¼±Çó´ó¼Ò°ïæ·ÒëÒ»ÏÂÒ»¾äÉó¸å»Ø¸´
ÒѾÓÐ8È˻ظ´
¡¾ÇóÖú/½»Á÷¡¿ÈõÈõµÄÎÊһϹØÓÚÓ¢ÎÄÎÄÏ×·Òë
ÒѾÓÐ21È˻ظ´

bessie86
½ð³æ (СÓÐÃûÆø)
- Ó¦Öú: 15 (СѧÉú)
- ½ð±Ò: 677.3
- ºì»¨: 1
- Ìû×Ó: 108
- ÔÚÏß: 77.5Сʱ
- ³æºÅ: 3054232
- ×¢²á: 2014-03-15
- רҵ: Íâ¹úÓïÑÔ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
scilence28: ½ð±Ò+10, ¡ïÓаïÖú, ±ÈÎҵĺÃһЩ£¬»¹ÊǺÜÖµµÃ½è¼øµÄ£¬·Ç³£¸Ðл¡£ 2014-03-24 12:30:33
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
scilence28: ½ð±Ò+10, ¡ïÓаïÖú, ±ÈÎҵĺÃһЩ£¬»¹ÊǺÜÖµµÃ½è¼øµÄ£¬·Ç³£¸Ðл¡£ 2014-03-24 12:30:33
|
In today's pharmaceutical field, as a drug carrier,bringing into full play of their targeted advantages, Clathrate and liposome are widely used in the preparation of new drugs. To solve the target cell delivery problem, use clathrate liposome as a drug carrier. Reviewed in this paper by combining clathrate and liposomes of their different advantages to control the stability of the drug and the drug problems, improve the absorption of drugs and clinical curative effect, thus, it will provide theoretical basis for the further research of targeted drug delivery system and it is looking to the future development direction in the future. Ï£ÍûÄܰﵽÄã |
2Â¥2014-03-24 11:20:24













»Ø¸´´ËÂ¥